MedTrace Logo

Vascularity Impact on the Treatment Outcome in Malignant Pleural Mesothelioma(VITMPM)

NCT02603315 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2016-06-01

No results posted yet for this study

Summary

The purpose of this study is to To assess the correlation between the predictive factor of vascularity (CD74) in malignant pleural mesothelioma and treatment results (response rate, and overall survival) .

Conditions

  • Malignant Pleural Mesotheliomas

Interventions

OTHER

marker CD74 and vascular endothelial growth factor VEGF

correlate the result of vascularity test done on paraffin blocks on both types of malignant pleural mesothelioma patients diagnosed and receive treatment and evaluated after treatment

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Amr S Saad, MD · Ain Shams University

  • Mahmoud Ellithy, MD · Ain Shams University

  • Doaa Atef, MD · Ain Shams University

  • Hoda Abougabal, MD · Ain Shams University

Eligibility

Min Age
39 Years
Max Age
84 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02603315 on ClinicalTrials.gov